Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine

Abstract Burkholderia pseudomallei is a Gram-negative, facultative intracellular bacillus that causes the disease melioidosis. B. pseudomallei expresses a number of proteins that contribute to its intracellular survival in the mammalian host. We previously demonstrated that immunization with OMVs de...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sarah M. Baker, Erik W. Settles, Christopher Davitt, Patrick Gellings, Nicole Kikendall, Joseph Hoffmann, Yihui Wang, Jacob Bitoun, Kasi-Russell Lodrigue, Jason W. Sahl, Paul Keim, Chad Roy, James McLachlan, Lisa A. Morici
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/94ff28ca65e5414195014839c12c40a0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:94ff28ca65e5414195014839c12c40a0
record_format dspace
spelling oai:doaj.org-article:94ff28ca65e5414195014839c12c40a02021-12-02T14:16:48ZBurkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine10.1038/s41541-021-00281-z2059-0105https://doaj.org/article/94ff28ca65e5414195014839c12c40a02021-01-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00281-zhttps://doaj.org/toc/2059-0105Abstract Burkholderia pseudomallei is a Gram-negative, facultative intracellular bacillus that causes the disease melioidosis. B. pseudomallei expresses a number of proteins that contribute to its intracellular survival in the mammalian host. We previously demonstrated that immunization with OMVs derived from B. pseudomallei grown in nutrient-rich media protects mice against lethal disease. Here, we evaluated if OMVs derived from B. pseudomallei grown under macrophage-mimicking growth conditions could be enriched with intracellular-stage proteins in order to improve the vaccine. We show that OMVs produced in this manner (M9 OMVs) contain proteins associated with intracellular survival yet are non-toxic to living cells. Immunization of mice provides significant protection against pulmonary infection similar to that achieved with a live attenuated vaccine and is associated with increased IgG, CD4+, and CD8+ T cells. OMVs possess inherent adjuvanticity and drive DC activation and maturation. These results indicate that M9 OMVs constitute a new promising vaccine against melioidosis.Sarah M. BakerErik W. SettlesChristopher DavittPatrick GellingsNicole KikendallJoseph HoffmannYihui WangJacob BitounKasi-Russell LodrigueJason W. SahlPaul KeimChad RoyJames McLachlanLisa A. MoriciNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Sarah M. Baker
Erik W. Settles
Christopher Davitt
Patrick Gellings
Nicole Kikendall
Joseph Hoffmann
Yihui Wang
Jacob Bitoun
Kasi-Russell Lodrigue
Jason W. Sahl
Paul Keim
Chad Roy
James McLachlan
Lisa A. Morici
Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
description Abstract Burkholderia pseudomallei is a Gram-negative, facultative intracellular bacillus that causes the disease melioidosis. B. pseudomallei expresses a number of proteins that contribute to its intracellular survival in the mammalian host. We previously demonstrated that immunization with OMVs derived from B. pseudomallei grown in nutrient-rich media protects mice against lethal disease. Here, we evaluated if OMVs derived from B. pseudomallei grown under macrophage-mimicking growth conditions could be enriched with intracellular-stage proteins in order to improve the vaccine. We show that OMVs produced in this manner (M9 OMVs) contain proteins associated with intracellular survival yet are non-toxic to living cells. Immunization of mice provides significant protection against pulmonary infection similar to that achieved with a live attenuated vaccine and is associated with increased IgG, CD4+, and CD8+ T cells. OMVs possess inherent adjuvanticity and drive DC activation and maturation. These results indicate that M9 OMVs constitute a new promising vaccine against melioidosis.
format article
author Sarah M. Baker
Erik W. Settles
Christopher Davitt
Patrick Gellings
Nicole Kikendall
Joseph Hoffmann
Yihui Wang
Jacob Bitoun
Kasi-Russell Lodrigue
Jason W. Sahl
Paul Keim
Chad Roy
James McLachlan
Lisa A. Morici
author_facet Sarah M. Baker
Erik W. Settles
Christopher Davitt
Patrick Gellings
Nicole Kikendall
Joseph Hoffmann
Yihui Wang
Jacob Bitoun
Kasi-Russell Lodrigue
Jason W. Sahl
Paul Keim
Chad Roy
James McLachlan
Lisa A. Morici
author_sort Sarah M. Baker
title Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
title_short Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
title_full Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
title_fullStr Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
title_full_unstemmed Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
title_sort burkholderia pseudomallei omvs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/94ff28ca65e5414195014839c12c40a0
work_keys_str_mv AT sarahmbaker burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT erikwsettles burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT christopherdavitt burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT patrickgellings burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT nicolekikendall burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT josephhoffmann burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT yihuiwang burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT jacobbitoun burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT kasirusselllodrigue burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT jasonwsahl burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT paulkeim burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT chadroy burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT jamesmclachlan burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
AT lisaamorici burkholderiapseudomalleiomvsderivedfrominfectionmimickingconditionselicitsimilarprotectiontoaliveattenuatedvaccine
_version_ 1718391682027749376